Obstetric cholestasis: current opinions and management

Area of Science:

• Hepatology
• Obstetrics
• Genetics

Background:

• Obstetric cholestasis (OC) is a pregnancy-specific liver disorder.
• Characterized by generalized pruritus without a rash, typically in the third trimester.
• Has a familial predisposition, suggesting a genetic basis.

Purpose of the Study:

• To explore the pathophysiology of OC, focusing on genetic mutations in bile acid transporters.
• To understand the role of pregnancy hormones in genetically susceptible women.
• To review diagnostic criteria and management strategies for OC.

Main Methods:

• Review of existing research on OC pathophysiology, genetics, and clinical management.
• Analysis of diagnostic markers including liver function tests and serum bile acid levels.
• Evaluation of therapeutic interventions like ursodeoxycholic acid and delivery timing.

Main Results:

• Genetic mutations in bile acid transporters may impair maternal excretion and affect fetal bile acid levels.
• Pregnancy hormones might trigger cholestasis in genetically predisposed individuals.
• OC is associated with increased perinatal risks, including fetal distress and intrauterine death.

Conclusions:

• Accurate diagnosis requires high suspicion, exclusion of other liver diseases, and confirmation of elevated serum bile acids.
• Ursodeoxycholic acid aids symptom relief and may offer cardioprotection.
• Active management with fetal monitoring and early delivery reduces intrauterine death risk, though may increase obstetric interventions.